Australia markets closed

Arovella Therapeutics Limited (ALA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1300+0.0100 (+8.33%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
405.898
405.898
295.81
257.347
532.69
Cost of revenue
203.52
203.52
207.056
222.75
200.969
Gross profit
202.378
202.378
88.754
34.597
331.721
Operating expenses
Research development
3,984
3,984
2,596
541.55
228.778
Selling general and administrative
3,537
3,537
2,793
2,094
2,165
Total operating expenses
9,883
9,883
7,685
4,701
5,127
Operating income or loss
-9,681
-9,681
-7,596
-4,666
-4,795
Interest expense
20.674
20.674
194.72
33.294
6.57
Total other income/expenses net
-509.958
-509.958
-833.271
-354.598
-5,818
Income before tax
-10,181
-10,181
-8,621
-5,047
-10,591
Income tax expense
0
0
0
0
-655.882
Income from continuing operations
-10,181
-10,181
-8,621
-5,047
-9,936
Net income
-10,181
-10,181
-8,621
-5,047
-9,936
Net income available to common shareholders
-10,181
-10,181
-8,621
-5,047
-9,936
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.06
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.06
Basic average shares
711,483
711,483
549,624
330,893
167,907
Diluted average shares
711,483
711,483
549,624
330,893
167,907